Li S - Search Results

1

A trinity STING-activating nanoparticle harnesses cancer cell STING machinery for enhanced immunotherapy.

Xia Y, Shi B, Wang K, Hu L, Wang Q, Xu S, Wang X, Xu P, She Y, Xie H, Li S, Yin L. Xia Y, et al. Among authors: li s. J Control Release. 2024 Nov 20;377:256-266. doi: 10.1016/j.jconrel.2024.11.035. Online ahead of print. J Control Release. 2024. PMID: 39561945

2

Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.

Chen B, Dai W, Mei D, Liu T, Li S, He B, He B, Yuan L, Zhang H, Wang X, Zhang Q. Chen B, et al. Among authors: li s. J Control Release. 2016 Nov 10;241:68-80. doi: 10.1016/j.jconrel.2016.09.014. Epub 2016 Sep 15. J Control Release. 2016. PMID: 27641831

3

The development of site-specific drug delivery nanocarriers based on receptor mediation.

Wang X, Li S, Shi Y, Chuan X, Li J, Zhong T, Zhang H, Dai W, He B, Zhang Q. Wang X, et al. Among authors: li s, li j. J Control Release. 2014 Nov 10;193:139-53. doi: 10.1016/j.jconrel.2014.05.028. Epub 2014 May 24. J Control Release. 2014. PMID: 24862317 Review.

4

cRGDfK-Grafted Small-Size Quercetin Micelles For Enhancing Therapy Efficacy Of Active Ingredient From The Chinese Medicinal Herb.

Xu P, Wang H, Hu H, Ye Y, Dong Y, Li S, Mei D, Guo Z, Wang D, Sun Y, Yu T, Qiao J, Zhang Q. Xu P, et al. Among authors: li s. Int J Nanomedicine. 2019 Nov 27;14:9173-9184. doi: 10.2147/IJN.S219578. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31819425 Free PMC article.

5

A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers.

Liang Y, Li S, Wang X, Zhang Y, Sun Y, Wang Y, Wang X, He B, Dai W, Zhang H, Wang X, Zhang Q. Liang Y, et al. Among authors: li s. J Control Release. 2018 Apr 10;275:129-141. doi: 10.1016/j.jconrel.2018.01.033. Epub 2018 Feb 2. J Control Release. 2018. PMID: 29408580

6

The circadian clock of anti-tumor immunity.

Xiang S, Li M, Li S. Xiang S, et al. Among authors: li s, li m. Chin J Nat Med. 2023 Jul;21(7):481-482. doi: 10.1016/S1875-5364(23)60431-5. Chin J Nat Med. 2023. PMID: 37517816 No abstract available.

7

A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid.

Liang Y, Li S, Wang X, He B, He B, Dai W, Zhang H, Wang X, Wang Y, Zhou D, Zhang Q. Liang Y, et al. Among authors: li s. Theranostics. 2017 Jul 23;7(13):3306-3318. doi: 10.7150/thno.20242. eCollection 2017. Theranostics. 2017. PMID: 28900511 Free PMC article.

8

Monoclonal antibodies: formulations of marketed products and recent advances in novel delivery system.

Cui Y, Cui P, Chen B, Li S, Guan H. Cui Y, et al. Among authors: li s. Drug Dev Ind Pharm. 2017 Apr;43(4):519-530. doi: 10.1080/03639045.2017.1278768. Epub 2017 Jan 22. Drug Dev Ind Pharm. 2017. PMID: 28049357 Review.

9

The impact of receptor recycling on the exocytosis of αvβ3 integrin targeted gold nanoparticles.

Cui Y, Song X, Li S, He B, Yuan L, Dai W, Zhang H, Wang X, Yang B, Zhang Q. Cui Y, et al. Among authors: li s. Oncotarget. 2017 Jun 13;8(24):38618-38630. doi: 10.18632/oncotarget.16955. Oncotarget. 2017. PMID: 28454098 Free PMC article.

10

Serum Free or Not: Two Distinct Recycling Mechanisms Mediated by Alpha v Beta 3 Integrin.

Cui Y, Li S, Chen B, He B, Yuan L, Dai W, Zhang H, Wang X, Zhang Q. Cui Y, et al. Among authors: li s. Curr Pharm Biotechnol. 2017 Nov 10;18(8):669-676. doi: 10.2174/1389201018666171004150050. Curr Pharm Biotechnol. 2017. PMID: 28982325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,197 results

Search Page

Filters